Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAZNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.19.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.214NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.284NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.3 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.318NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
R.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ML.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.283NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.96NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
L.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.423NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used